Welcome to the Crane Company First Quarter 2025 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be opened for your questions following the presentation. [Operator Instructions] I would now like to turn the conference over to Allison Poliniak, Vice President of Investor Relations.

Thank you, operator, and good day, everyone. Welcome to our first quarter 2025 earnings release conference call. I am Allison Poliniak, Vice President of Investor Relations. On our call this morning, we have Max Mitchell, our Chairman, President and Chief Executive Officer; Alex Alcala, Executive Vice President and Chief Operating Officer; and Rich Maue, our Executive Vice President and Chief Financial Officer, along with Jason Feldman, Senior Vice President, Treasury, Tax and Investor Relations, who is on for Q&A. We will start off our call with a few prepared remarks from Max, Alex and Rich, after which we will respond to your questions. And just a reminder, the comments we make on this call will include some forward-looking statements. We refer you to the cautionary language at the bottom of our earnings release and also in our annual report, 10-K and subsequent filings pertaining to forward-looking statements. Also during the call, we will be using some non-GAAP numbers, which are reconciled to the comparable GAAP numbers in tables at the end of our press release and accompanying slides of presentation, both of which are available on our website at www.craneco.com in the Investor Relations section. Now let me turn the call over to Max.

Thank you, Allison, and thanks, everyone for joining the call today. May you live in interesting times. The origins of the phrase are unknown, but we've all heard it used as a sarcastic euphemism for times of challenge and uncertainty, some think it's intended more as a curse. But either way, it's times like these that we prepare for at Crane. As a leader of the global diversified manufacturer and for my entire team, what a fantastic time for us to continue to hone our strategic thinking, processes for reacting to fast changing events, and our ability to execute in an environment that's in constant flux. And an experience, the whole team embraces and relishes in this environment as we continue to have the opportunity to grow through adversity. There are many potential scenarios for how the current dislocation progresses over the course of 2025 and beyond. What's common across those scenarios is my strong belief that Crane will emerge in an even stronger competitive position than when we entered this year and off to a very strong start to 2025. Adjusted EPS was $1.39, driven by an impressive 7.5% core sales growth, reflecting strength across both Aerospace & Electronics and Process Flow Technologies. Core orders were also solid, up 16% in the quarter, driven primarily by the ongoing strength in our Aerospace & Electronics business and with Process Flow Technologies also ahead of our expectations. As we exited 2024, we had a very positive outlook for 2025 given the expectation of executing successfully on our strategy and growth initiatives, along with favorable macroeconomic outlook. As the quarter progressed, we gained confidence in our path to exceed the guidance we provided in January. However, given recent economic developments, policy decisions outside of our control, the balance of the year is…

Thanks, Max. Yes. Our teams are having great fun. I must admit, I wish we can enjoy a few moments of boring and repetitive. Before I get into the segments, let me provide some insights into our tariff exposure. Overall, about 7% to 8% of our cost of goods sold consists of materials and components that are directly imported into the United States, another 3% to 4% of cost of goods sold are intercompany sales into United States, a portion of which is exempt from tariffs. Our direct imports into the United States are skewed somewhat towards Process Flow Technologies with Aerospace & Electronics relying more heavily on a U.S. supply base. For Process Flow Technologies, the largest exposure is China where we procure bio valves, pumps, castings and motors. However, our total China exposure is well below 3% of Crane's total cost of goods. The other notable exposures for PFT are India, primarily related to castings and Thailand, primarily for machine parts. Neither of those exposures reaches 1% of Crane's total cost of sales. At Aerospace & Electronics, the primary source of import is Malaysia, largely related to printed circuit boards and only 1% to 2% of total cost of sales for Crane overall. While much smaller, A&E does also import wire harnesses, machine parts and power sources from a number of countries, none of which is particularly material. We expect to offset the majority of the potential tariff impact through price and productivity. We have demonstrated consistently differentiated execution through cycles with this leadership team. The cadence and discipline of the Crane business system, our machine, along with our performance based culture are even more valuable in times like these as they enable us to make data-driven decisions quickly with flexibility to adapt as conditions change and with…

Thank you, Alex, and good morning, everyone. Starting off with total company results. We drove 7.5% core sales growth in the quarter with strength across both segments. Adjusted operating profit increased 18%, driven by volumes, solid net price and productivity. In the quarter, core FX neutral backlog was up 12% compared to last year, driven by outsized strength at Aerospace & Electronics and core orders were up 16% compared to last year as well, also driven by Aerospace & Electronics, but also modest growth in Process Flow Technologies that was a bit ahead of our expectations. Further, we are in a net cash position and have more than $1.5 billion in debt capacity today for M&A. A few more details on the segments in the quarter starting with Aerospace & Electronics. Sales of $249 million increased 10% in the quarter with all of that growth organic. And even with the continued high level of sales growth, notably our record backlog of $960 million increased even further up 21% year-over-year and up 11% sequentially. Total aftermarket sales increased 20%, with commercial aftermarket sales up 19% and military aftermarket up 24%, and OEM sales increased 6% in the quarter with 10% growth in commercial and up 1% in military. Adjusted segment margin of 26%, a record high for the segment, increased 360 basis points from 22.4% last year, primarily reflecting higher volumes, price net of inflation and productivity. At Process Flow Technologies, in the quarter, we delivered sales of $309 million up 9%, driven by solid core sales growth of 5% in the quarter, along with a 5% benefit from the CryoWorks and Technifab acquisitions, offset by a point of unfavorable foreign exchange. Compared to the prior year, core FX-neutral backlog decreased 6% and core FX neutral orders were up 2%, both…

Thank you. The floor is now open for questions. [Operator Instructions] Our first question will come from Damian Karas with UBS. Your line is open.

Hey, Damian.

Hey. Good morning, Max. Hey, Rich. Hope you can dodge these wrenches about to come your way.

Thanks, Damian.

Yes. No, I appreciate all the details around your main tariff exposures. Maybe you could just get a little bit more clarity on the updated guidance. To what extent is price contributing to your sales guide at this point? And just kind of considering the strength of the first quarter orders and that uptick in backlog, is it fair to assume that, that's longer lead time backlog that's really more 2026 and beyond?

Yeah. So Damian, just to maybe hit your first question first on price. Yeah. We would expect to see somewhere in the vicinity of about 3% overall, more heavily weighted to PFT for sure, perhaps a little bit higher in the PFT segment, a little lower in A&E. So just overall, that's what we would expect for us to offset the majority or most of the tariff impact. As it relates to backlog, maybe just a little bit of color to provide there. Certainly, Aerospace & Electronics was significant overall in the quarter and the growth in the backlog fairly broad based. Maybe some color, aftermarket continues to be fairly strong as you saw. Alex mentioned also the comps in the latter part of the year, but aged fleet continues to be a dynamic or signature in the market space. Retirement is not happening at the levels that would cause you to believe a significant decline in aftermarket. So we feel good about the build that's happened in aftermarket. And then on OE, it was really a combination of both commercial and defense from an orders point of view. On commercial, obviously, the build rates are continuing and widespread there as well, right, between Boeing, Airbus and Comet, frankly, in the quarter. Defense, to your point, a little bit, there's some multiyear orders in there, too, so it gives us even further confidence in 2026 already. So a few multiyear orders that contributed to the strength in the quarter.

But in terms of the guide, in relation to the guide and the strength of the backlog, yes, it's related to the length of those orders that's reading through beyond '25. Right, Rich?

Yeah.

Okay. Got it. That makes total sense. And then a follow-up to some of those comments on defense. I mean, within A&E, if you look at some of the details of the $150 billion defense package, that's in reconciliation, are there any items that kind of stand out to you as Crane programs or growth drivers in the future?

Yeah. I would say just overall, we have such a broad exposure, Damian, across defense platforms, whether it's fixed wing, even rotary, even -- we saw some nice aftermarket demand on rotary actually in the quarter on the CH-47 on aftermarket. But overall, from a spend point of view, whether it's munitions or aircraft or radar applications, as you know, where we have a particular strength, we feel really good about the approvals and where we see spend being allocated as we look forward into '26.

Some of those themes, as Rich was just mentioning, I would call out, munitions replenishment unfortunately, in this global environment. Aging military upgrades, that's a key theme. I would say electrification is another key theme for the future, which we highlighted at Investor Day also. So those are some of the major thematic drivers that we continue to see strength through the decade.

Understood. Thanks, again. Good luck out there. I’ll pass it along.

Thanks, Damian.

Thanks, Damian.

Thank you. Our next question will come from Scott Deuschle with Deutsche Bank. Your line is open.

Hey, good morning.

Good morning, Scott.

Rich, can you characterize the growth split between volume and price that you saw at A&E this quarter?

Yeah. It was roughly 50-50. So right -- almost right down the middle.

Okay. And was commercial OE contributing very materially to the pricing gains that the segment experienced?

Yeah. I don't have the full breakout of that, but certainly, we've been making nice progress on certain areas in commercial OE, but clearly, there has been, whether it's from existing contracts with indexed increases or changes that we might have made in response to contracts that needed to be addressed. But I don't have the specific breakout. That was pretty healthy, I would say, across both aftermarket and commercial.

Okay. Just to clarify, do any major commercial OE LTAs reprice this quarter that you didn't have repriced last quarter? I'm just trying to understand the sequential EBIT growth at A&E.

No.

Okay. And then Rich, consensus has EBIT dollars down at A&E over the remainder of the year versus what you just reported at A&E this quarter. I guess -- I realize it's an environment of uncertainty. But is there any discrete reason why you would think that would be the case and EBIT dollars would decline from these levels?

Yeah. So what I would say is that in the quarter, we had a very strong quarter overall, as you saw with the leverage of 60% in A&E. We had decent mix. We had strong engineering sales, completing a few, I think, major development programs that had some nice margin to them. So a few things is what I would say, added up overall in the quarter that contributed to that 60%. Alex mentioned in his prepared remarks that the comps will start to kind of move down. But overall, there's nothing that would suggest any sort of overall weakening to any significant degree. There was perhaps just a few items in the quarter that we benefited from.

Okay. And is COMAC still taking delivery of the parts you make for the C919, even with retaliatory tariffs they have?

Yeah. Thanks for the question. This is Alex. We actually met with COMAC a couple of weeks ago to look at the ramp-up and everything has moved forward very smoothly. They have a big ramp up projected this year and they're on track. They're still taking deliveries to emphasize the importance of staying on track. The aftermarket as well. So everything progressing quite well. As you know, we have a really strong position with that 919 platform. And they're also in the development of the 929, the wide-body, which we expect to also have a great position. Our team is doing a great job. A lot of our key members were in China last week and all looks positive from that regard.

Okay. Thank you. I’ll pass it on.

Thanks, Scott.

Thanks, Scott.

Thank you. Our next question will come from Jeff Sprague with Vertical Research Partners. Your line is open.

Hey. Thank you. Good morning. Hey, good morning, Max. A high level one for you first and then a couple of detailed questions. In your opening commentary, just talking about emerging stronger and the like, was that just kind of an overarching view that kind of sweating the organization, exercising the muscle, trial by fire makes you better or do you actually see some places maybe where you have competitive footprint advantage or other advantages versus competitors that you might be able to leverage here?

Both, Jeff, both. I think any time that you exercise like this, it sharpens the sword. The other is, we're seeing some opportunities where our competitors, our position, some decisions that they're making that we think we have some openings.

Interesting. Okay. Great. And then, just on the tariffs, again. So I think the 7% to 8% of COGS, call it, $100 million or so run rate. I didn't follow quite what Alex was getting at with the additional 3% to 4% intercompany. Was that kind of a USMCA comment and not a cost headwind or maybe you could just elaborate on what that meant and whether I'm right on the roughly $100 million?

Yes, go ahead.

Yes. Thank you. Thank you for the question. Yeah. The $100 million was related to direct imports from external suppliers, and then there's another 3% or 4% of inter unit. Some of that is a TAM because of USMCA from the inter unit shipments. But those are the imports, that's not the tariff impact that we expect in our P&L. So that's just the overall -- the tariff impact is more around the $60 million range for this year, considering all factors, indirect impact on suppliers, and that's mostly on the PFT side because as you know, our aerospace business is very heavily sourced domestic.

Right. So we'll call it $100 million or so direct annualized, $60 million on an in-year basis. And then just maybe one other one for you, Alex. Just where you might see some demand risk in your business? I'm kind of thinking Chem, right? Those guys are cutting CapEx and chem prices are declining. Is that where you've hedged your guide from an end demand standpoint and maybe if there's other verticals within PFT that you'd want to address?

Yeah, Jeff. So in PFT, when we think about the MRO side and the project side, so across all verticals. I think the MRO side, usually, when there's softness remains somewhat consistent, and that's all about the project activity and shifting to the right. So on the chemical side, what we've seen last year and this year, different dynamics by region. U.S. continued to move. Middle East continued to move forward. Europe softening. We did start hearing customers thinking about delaying decisions, trying to see how this tariff points out. So we did make assumptions on projects shifting to the right in particular, in the chemical in the United States, but also in other regions. [indiscernible] our guidance.

Great. And then one quick one for Rich. FX still guiding minus 1. It sounds like you're dropping a couple of pennies in your back pocket there. Maybe just -- was that a 330 rates or maybe you update us on that?

Yeah. That's exactly what it is. It's -- we just -- we're not going to -- all the changes that can happen there. And so we just stuck with 330 rates. There's been some favorability here. We'll see if it sticks, but your hunch is correct. That's a couple of pennies in my pocket.

Thank you. Our next question comes from Nathan Jones with Stifel. Your line is open.

Good morning, Nathan.

Good morning, everyone.

Good morning.

In the spirit of jokes, I won't say that I wish I was there, but I do wish you were here.

Good. I like it. Might you ask.

I guess the first question is on supply chain. During COVID, there was obviously a lot of supply chain disruption and you guys have components that go into other systems. I'd be less concerned about your ability to manage your supply chain and more concerned about people who supply into those same projects being able to manage their supply chain. Do you see any risk to any of -- any parts of the business that could arise just from other impacts on other suppliers' supply chains that could impact your ability to -- or your customers' ability to finish projects and take delivery of products similar to maybe what happened during COVID?

Yeah. Nathan, thanks for your question. This is Alex. So I think you have to think about separately from PFT and A&E perspective. On the PFT side, I would not expect anything significant that supply chain has returned since last year to normal rates. It is pretty stable. Of course, the shipment lanes and things like that from Asia are getting clogged up and so forth. But I would not expect any significant change in supply chain ability to deliver on that side. I think on the A&E side, through here the first month, we saw a pretty stable, slightly improving. I know everybody saw on the news, the issues with the SBS Fastener facility and the Chicago Magnesium Foundry that did not directly impact us. That said, these supply -- some companies try to adjust their supply chains and the tariffs won't help, right, the supply chain improvement in aerospace, for sure. So we would expect some lead time extensions as people get out of certain region and try to get to others and capacity constraints from some suppliers from those movements in supply chain but we're not seeing any major disruption caused by that. And we're planning for some of those lead times to, in some areas, be extended, and that's what we factored in as well.

Thanks for that. I guess my second question, you talked about PFT orders being a bit stronger than you anticipated in the first quarter. I guess the question there is, do you think customers were prepositioning ahead of tariff-related price increases? And then did you guys preposition some inventory in front of tariffs during the first quarter yourselves?

Yeah. Good question. On the inventory, no, we didn't. We have experience managing these tariffs. It's never -- as you know, we're engineered to order. It's never the right inventory if you try to play game. So from that standpoint, we didn't. On the prebuy, I mean, we did hear some activity prebuy from distributors stocking a bit more, not really significant. I would say, it's not material. Really what drove this better than expected are some projects that have been tracking for a while now since last year that hit in the quarter that drove some of that favorability. So I would say a little bit of pre-buy but not anything major.

Great. Thanks very much for taking my questions and I’ll see you in the dark side of the moon.

Thanks, Nathan. Well done.

Thank you. [Operator Instructions] Our next question will come from Ronald Epstein with Bank of America. Your line is open.

Hey, good morning. This is Jordan on for Ron.

Excellent.

Hi Jordan.

A couple of questions. First one for M&A, have you guys seen any slowdown in deals or positives happening just because of the macro?

No, we haven't. We haven't seen any slowdown. It's very, very active for us.

Okay. And then on Boeing's call, they made a comment about their buffer stock having been high to stabilize the supply chain and that it would go back down to normalized levels. You guys have been very good about controlling the inventory that you guys have in the channel. Are you concerned that although for other suppliers that you might be feeding into that would be getting destocked?

I mean I think Boeing has done a great job, being transparent on their inventory position with us. I imagine with other suppliers as well. So we are very well aligned to what they need and are expecting, and we're planning to support that. So our factories are well in tune and efficient to support that ramp up. So my understanding is that it is the same with many other suppliers that are well in tune with Boeing's inventory position and planning appropriately.

Okay. Got it. Thank you guys so much.

Thanks, Jordan.

Thanks, Jordan.

Thank you. Our next question will come from Matt Summerville with D.A. Davidson. Your line is open.

Good morning, Matt.

Thanks. Good morning. Just a couple of follow-ups. That $60 million, I just want to clarify, is that the unmitigated number, meaning that is the magnitude by which your COGS are going higher, all else equal as a result of the tariffs? I just want to be clear on that.

Yeah. That would be the gross number, right, that we will substantially mitigate.

Assuming these tariffs exist through the entire balance of the year, no change, up or down.

Got it. Thank you for that clarification. And then you talked just very briefly on the chemical market with respect to PFT. Can you maybe do a little bit more of a deeper dive in terms of what you're seeing across both the MRO and project side of the business, geographic color around the major end market buckets and product lines that you guys typically refer to in that business?

Yeah. I mean for PFT, as you know, chemical really strong position. We have a substantial presence globally. I think we went into the year with expectations different by region, and we saw that play out in Q1. So in the Americas, we saw positive growth both on MRO and private activity where customers are expanding brown side, driving efficiency, upgrades, things of that nature, Middle East similar, continued investment in growth. And then since last year in Europe, it's been soft, declining and that has continued. China as well, somewhat soft and Asia-Pac kind of mixed. So kind of how we closed out last year was the first four months of the year. Now going forward, like I mentioned, we expect some of that project activity in the Americas to shift to the right, some softening demand versus what we saw in Q1 and that's what we baked into our guidance.

Thank you for that, Alex. Can you talk about some of the other end markets in that business as well, what you're seeing with cryo, industrial, automation, water, wastewater, etc.?

So water, wastewater in the quarter, orders were strong, up. So we feel good about that, continuing. Cryogenics has been our fastest-growing segment, double digits. So that has been really an exciting platform that we've added. And continue to expand and gain share and take advantage of the market. A lot of that is driven by space launch activity, where our applications are used for the platforms that are being built out in various parts of the country. And then general industrial activity has, in the first part of this year in the quarter, has been slightly up. So I think overall, a lot of positives in the first quarter, I think partially offset by what I mentioned in chemical, particularly in Europe and other parts of the world as well.

Got it. And then maybe just one final one. Rich, as we look out over the balance of the year, is there anything you would want to draw our attention to in terms of kind of the remaining earnings cadence as we move through Qs 2, 3 and 4?

Yeah. I think the high level would be, as you're looking at next quarter, just slightly down, slightly. And then I would think of the full year as more equally weighted, frankly, first half, second half overall.

Got it. Thank you.

You’re welcome.

Thank you. Our next question will come from Justin Ages with CJS Securities. Your line is open.

Good morning, Justin.

Good morning. Question, there's been a bunch of headlines about travel being down given the political environment. Have you seen or do you expect to see that impacting your business at all?

Look, we're seeing the same headlines, reading the same reports, but we don't -- we're not seeing it read through. I mean I think this aged fleet is still requiring the same level of maintenance. Aftermarket continues to be strong. Deliveries are still not where they need to be in terms of the replacement cycle. Boeing is trying to ramp up. So we just don't see it. And we're not hearing it from our customers either.

All right. That's helpful. And then following up on the M&A commentary, can you give us any indication of how far along or in any processes in PFT or A&E, any deals that you guys are in?

Yeah. The first two weeks of May, Alex and I will be traveling with the teams. We've got kind of nonstop due diligence across multiple acquisitions, both domestically and international in terms of locations. So we're very, very active in the process. Really nice fit, really nice fit, attractive. We're going to be competitive. I'm hopeful that we'll have some activity announced in 2025.

All right. Great. I appreciate you taking the questions. Thank you.

[Operator Instructions] Our next question will come from Tony Bancroft with Gabelli Funds. Your line is open.

Good morning.

Good morning, Tony.

Hey. Great job on the quarter, very well done. I just want to -- I know you've pretty much said that the tariffs are going to be relatively mitigated and not an impact. But on the aero side, you're hearing comments from the China Trade Ministry yesterday about what disruptions in China and in commercial travel. And then you've seen like people in France, you're seeing aerospace and defense industry talking about tariff exemptions. How do you see this all playing out? Maybe it's not as impactful to you, but maybe you could talk to that a little bit next.

Well, it's anybody's guess, honestly, in terms of how it moves forward. But quite honestly, I'm more optimistic, quite honestly. I think things will get resolved. I think our trading partners, while there's certainly a number of serious issues that are being addressed, our global environment is too important to one another. And I think these things will get sorted. I think when that does, it's going to be very positive for all of us as we move forward.

Thanks so much. Great job.

Thanks, Tony.

Thank you. This concludes the Q&A portion of today's call. I would now like to turn the floor over to Max Mitchell for closing remarks.

Thank you all for attending today. Our focus today is executing on everything within our control, reacting swiftly to what is outside our control, serving our customers and continuing to invest in all of our growth initiatives and technology road maps and driving profitable growth. I fully expect to emerge from this dislocation in an even stronger competitive position than when we entered the year. As the late great Gene Hackman said, challenges are what makes life interesting, overcoming them is what makes life meaningful. Our teams at Crane continue to make our lives hugely meaningful as we continue to deal successfully with life's interesting challenges. Thank you all for your interest in Crane and your time and attention this morning, and have a great day.

Thank you. This concludes today's Crane Company's first quarter 2025 earnings conference call. Please disconnect your line at this time, and have a wonderful day.